Target Details
| UniProt AC | P01584 |
|---|---|
| Gene Symbol | IL1B |
| Protein Name | Interleukin-1 beta |
| Organism | Homo sapiens |
| Entry Name | |
| Organism Category | Human |
| Pfam Domains | PF00340 (IL1) PF02394 (IL1_propep) |
Summary
- Multi-target molecules 148
- Clinical molecules 0
- Avg pChEMBL 6.92
KEGG Pathways (44)
- AGE-RAGE signaling pathway in diabetic complications
- African trypanosomiasis
- Alcoholic liver disease
- Alzheimer disease
- Amoebiasis
- Antifolate resistance
- C-type lectin receptor signaling pathway
- Chagas disease
- Coronavirus disease - COVID-19
- Cytokine-cytokine receptor interaction
- Cytosolic DNA-sensing pathway
- Fluid shear stress and atherosclerosis
- Graft-versus-host disease
- Hematopoietic cell lineage
- Herpes simplex virus 1 infection
- Human cytomegalovirus infection
- IL-17 signaling pathway
- Inflammatory bowel disease
- Inflammatory mediator regulation of TRP channels
- Influenza A
- Legionellosis
- Leishmaniasis
- Lipid and atherosclerosis
- MAPK signaling pathway
- Malaria
- Measles
- NF-kappa B signaling pathway
- NOD-like receptor signaling pathway
- Necroptosis
- Non-alcoholic fatty liver disease
- Osteoclast differentiation
- Pathogenic Escherichia coli infection
- Pathways of neurodegeneration - multiple diseases
- Pertussis
- Prion disease
- Rheumatoid arthritis
- Salmonella infection
- Shigellosis
- TNF signaling pathway
- Th17 cell differentiation
- Toll-like receptor signaling pathway
- Tuberculosis
- Type I diabetes mellitus
- Yersinia infection
Active Molecules (148)
| InChIKey | pChEMBL | Type | Targets | Clinical | |
|---|---|---|---|---|---|
BGHBRFNKKNQTOB
|
9.4 | IC50 | 2 | — | |
XYJKIUDOTQKQBQ
|
9.4 | IC50 | 2 | — | |
IXZOHGPZAQLIBH
|
9.3 | IC50 | 8 | — | |
UVVZGYXCKGWWCC
|
9.1 | IC50 | 2 | — | |
IXZOHGPZAQLIBH
|
9.1 | IC50 | 6 | — | |
KXAUXHBXAIZBIR
|
9.0 | Ki | 2 | — | |
YIKMAFZEIMZOGL
|
9.0 | Ki | 2 | — | |
IXZOHGPZAQLIBH
|
8.2 | IC50 | 6 | — | |
HAMGPBKPACGWND
|
8.1 | IC50 | 2 | — | |
UVSMNLNDYGZFPF
|
7.3 | IC50 | 7 | — | |
RSNPAKAFCAAMBH
|
7.3 | IC50 | 8 | — | |
ALBOHFZHNNBACL
|
7.3 | IC50 | 2 | — | |
BBQGQUYUBIGQSH
|
7.3 | IC50 | 2 | — | |
DMRKNPNOKKHHGK
|
7.3 | IC50 | 2 | — | |
DZPFVUSVHAVVJR
|
7.3 | IC50 | 2 | — | |
FJOZGEOEQGSXAW
|
7.3 | IC50 | 2 | — | |
FVDOWIVOMIRGRI
|
7.3 | IC50 | 2 | — | |
FVDOWIVOMIRGRI
|
7.3 | IC50 | 2 | — | |
FVDOWIVOMIRGRI
|
7.3 | IC50 | 2 | — | |
FVIUMNSKFAZYCV
|
7.3 | IC50 | 2 | — | |
GGDYUQIVEMLAOC
|
7.3 | IC50 | 2 | — | |
GGJAAUYAOVPEKL
|
7.3 | IC50 | 2 | — | |
GNVRZHHSFIRPCQ
|
7.3 | IC50 | 2 | — | |
HMQCQONQOWJVFE
|
7.3 | IC50 | 2 | — | |
HYJYXNXTCDSEDH
|
7.3 | IC50 | 2 | — | |
IFBFEVQYBARLBL
|
7.3 | IC50 | 2 | — | |
JFQOYWWBQIMYDO
|
7.3 | IC50 | 2 | — | |
JGKPQHVZFCKKIN
|
7.3 | IC50 | 2 | — | |
KWQDZOPUCOBVSQ
|
7.3 | IC50 | 2 | — | |
LIWOJUJKVLFKLS
|
7.3 | IC50 | 2 | — | |
LLBDMFJIXKFZFS
|
7.3 | IC50 | 2 | — | |
LZMOSSPPMWPJOX
|
7.3 | IC50 | 2 | — | |
MDPSJCJCQNIUMX
|
7.3 | IC50 | 2 | — | |
MEPUDURFSDHOKI
|
7.3 | IC50 | 2 | — | |
MFTWCPAPYQQCLJ
|
7.3 | IC50 | 2 | — | |
NRIQUWDZDZKGOG
|
7.3 | IC50 | 2 | — | |
NRLRXEUUQBFCSQ
|
7.3 | IC50 | 2 | — | |
OIPFHTDSPCKTSD
|
7.3 | IC50 | 2 | — | |
OIPFHTDSPCKTSD
|
7.3 | IC50 | 2 | — | |
OYWYCRPFZPTSLP
|
7.3 | IC50 | 2 | — | |
PAGDEUIXKSZUKR
|
7.3 | IC50 | 2 | — | |
PBMUASNWNGAALP
|
7.3 | IC50 | 2 | — | |
PSPCMSHPSBYOPA
|
7.3 | IC50 | 2 | — | |
PSPCMSHPSBYOPA
|
7.3 | IC50 | 2 | — | |
QFZVGGXYGMKBDU
|
7.3 | IC50 | 2 | — | |
QUPJJASNZIHKTK
|
7.3 | IC50 | 2 | — | |
QXXIDFSPMZNWAG
|
7.3 | IC50 | 2 | — | |
RNQUMBSSZCSQBN
|
7.3 | IC50 | 2 | — | |
RSTDDEJXUGJOEL
|
7.3 | IC50 | 2 | — | |
STOHQRSSMDBDPX
|
7.3 | IC50 | 2 | — |